On October 31, the Ninth Circuit Court of Appeals decided a case challenging the United States Department of Agriculture's ("USDA") mandatory ...

In Natural Grocers v. Rollins, the U.S. Court of Appeals for the Ninth Circuit significantly upended certain parts of the U.S. Department ...

Researchers have developed the first bioengineered human bone-marrow model to test CAR T-cell therapies for ­acute myeloid ...

ReNerve (ASX:RNV) is a cutting-edge biotech developing “ready-to-use” products for nerve repair and regeneration.

A new biomimetic protein matrix can regenerate natural enamel layers, restore strength, and protect teeth against erosion and ...

As of Monday, November 10, Organogenesis Holdings Inc.’s ORGO share price has surged by 7.82%, which has investors ...

Q3 2025 Earnings Call Transcript November 12, 2025 Humacyte, Inc. beats earnings expectations. Reported EPS is $-0.14, ...

Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced the details of six ...

From silver nanofibers to smart, sensory-packed dressings, the next generation of wound-healing technology is blurring the ...

Total revenues of $753,000 for third quarter, and $1,571,000 for first nine months of 2025, from sales and collaborative research agreement - - Major advances in pipeline as Humacyte moves closer to ...

Dragon Ball Super can fulfill Gohan's unmet potential, offering new forms and challenges that may finally give him a central ...

The US has a diabetic wound problem. An estimated 1 million patients with diabetes in the US develop a foot ulcer annually.